Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...
Cinrebafusp alfa is under clinical development by Pieris Pharmaceuticals and currently in Phase I for Gynecological Cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback